Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer
Manish Kohli(Mayo Clinic in Arizona), Sheng Zhang(Fudan University Shanghai Cancer Center), Douglas W. Mahoney, Deepak M. Sahasrabudhe(University of Rochester Medical Center), Roman M. Zenka(Mayo Clinic in Florida), Ann L. Oberg(University of Minnesota), Robert Sherwood(Cornell University), Rui Qin(Regeneron (United States)), Yuzi Zhang(Mayo Clinic in Florida), Shaun M. Riska(Mayo Clinic in Florida)
Cited by 18
Related Papers
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
|Journal of Clinical Oncology|2018|1.1k
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
|Annals of Surgery|2008|461